UT Health San Antonio

Mingjiang Xu, Ph.D.

Professor

CTRC Council Distinguished Chair in Oncology

Currently seeking M.S. & Ph.D. students

My research aims to define whether and how specific changes in the epigenetic landscape are capable of influencing the initiation and progression of blood cancers and to identify the biochemical mediators involved in these processes. Our studies are expected to provide insights into cancer transcription regulation via DNA/RNA hydroxymethylation and long non-coding RNA (lncRNA)-mediated long-range chromosome interaction.  

Related Media